Itopride HCI 50 mg

DRUG3 trials

Sponsors

Abbott, Chulalongkorn University, Ain Shams University

Conditions

AnesthesiaFeeding IntoleranceIrritable Bowel SyndromeSemaglutide-Induced Gastric Motility

Phase 2

Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syndrome With Predominant Constipation

CompletedNCT01027260

AbbottIrritable Bowel Syndrome

Start: 2008-06-30End: 2010-09-30Updated: 2013-06-18

Phase 4

Efficacy of Itopride Versus Metoclopramide in Hospitalized Medicine Patients With High Gastric Residual Volume

Not yet recruitingNCT07031479

Chulalongkorn UniversityFeeding Intolerance

Start: 2025-07-01End: 2026-09-30Target: 86Updated: 2025-06-22

Effect of Itopride on Semaglutide Gastroparesis

RecruitingNCT07254715

Ain Shams UniversityAnesthesia, Semaglutide-Induced Gastric Motility

Start: 2025-12-31End: 2026-04-30Target: 60Updated: 2025-11-28